Teladoc Health Statistics

Total Valuation

Teladoc Health has a market cap or net worth of MXN 24.51 billion. The enterprise value is 30.25 billion.

Market Cap	24.51B
Enterprise Value	30.25B

Important Dates

The next estimated earnings date is Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	177.47M
Shares Outstanding	n/a
Shares Change (YoY)	+3.59%
Shares Change (QoQ)	+0.58%
Owned by Insiders (%)	1.11%
Owned by Institutions (%)	70.14%
Float	175.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.53
PB Ratio	0.96
P/TBV Ratio	n/a
P/FCF Ratio	4.77
P/OCF Ratio	4.57
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 59.86, with an EV/FCF ratio of 5.89.

EV / Earnings	-7.38
EV / Sales	0.66
EV / EBITDA	59.86
EV / EBIT	n/a
EV / FCF	5.89

Financial Position

The company has a current ratio of 2.70, with a Debt / Equity ratio of 0.75.

Current Ratio	2.70
Quick Ratio	2.33
Debt / Equity	0.75
Debt / EBITDA	37.51
Debt / FCF	3.72
Interest Coverage	-8.26

Financial Efficiency

Return on equity (ROE) is -15.42% and return on invested capital (ROIC) is -4.04%.

Return on Equity (ROE)	-15.42%
Return on Assets (ROA)	-3.48%
Return on Invested Capital (ROIC)	-4.04%
Return on Capital Employed (ROCE)	-7.22%
Revenue Per Employee	9.16M
Profits Per Employee	-810,493
Employee Count	5,500
Asset Turnover	0.79
Inventory Turnover	19.86

Taxes

Income Tax	-485.98M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -36.49% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-36.49%
50-Day Moving Average	147.68
200-Day Moving Average	171.15
Relative Strength Index (RSI)	49.73
Average Volume (20 Days)	1,742

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.52

Income Statement

In the last 12 months, Teladoc Health had revenue of MXN 46.37 billion and -4.10 billion in losses. Loss per share was -23.44.

Revenue	46.37B
Gross Profit	32.37B
Operating Income	-3.28B
Pretax Income	-4.59B
Net Income	-4.10B
EBITDA	296.59M
EBIT	-3.28B
Loss Per Share	-23.44

Full Income Statement

Balance Sheet

The company has 13.32 billion in cash and 19.11 billion in debt, giving a net cash position of -5.79 billion.

Cash & Cash Equivalents	13.32B
Total Debt	19.11B
Net Cash	-5.79B
Net Cash Per Share	n/a
Equity (Book Value)	25.53B
Book Value Per Share	143.98
Working Capital	12.61B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.37 billion and capital expenditures -227.55 million, giving a free cash flow of 5.14 billion.

Operating Cash Flow	5.37B
Capital Expenditures	-227.55M
Free Cash Flow	5.14B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 69.80%, with operating and profit margins of -7.06% and -8.84%.

Gross Margin	69.80%
Operating Margin	-7.06%
Pretax Margin	-9.89%
Profit Margin	-8.84%
EBITDA Margin	0.64%
EBIT Margin	-7.06%
FCF Margin	11.08%

Dividends & Yields

Teladoc Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.59%
Shareholder Yield	-3.59%
Earnings Yield	-16.73%
FCF Yield	20.96%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Teladoc Health has an Altman Z-Score of -6.41 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.41
Piotroski F-Score	4